New Approaches in the Management of Submacular Hemorrhages.

The editorial in Ophthalmologica discusses new approaches in managing submacular hemorrhages (SMH), a severe complication of neovascular age-related macular degeneration. Treatment options include anti-VEGF therapy, office-based interventions, and various surgical methods like vitrectomy and tissue plasminogen activator (tPA) injection. Studies emphasize the importance of timely intervention to preserve visual function and the need for individualized treatment plans based on the severity of the hemorrhage. Research is ongoing to determine the optimal approach for different types of SMH, with a focus on integrating tPA with anti-VEGF therapies to improve visual outcomes. [Extracted from the article]